Back to search
SCHIZOPHRENIA 1 (Disorder)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SCHIZOPHRENIA 1 (Disorder) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which SCHIZOPHRENIA 1 (Disorder) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study examines whether an early-detection program for psychosis can shorten the time patients remain untreated after the first appearance of psychotic symp…
This is a single site clinical trial in which 12 participants with schizophrenia will be randomized to one of three doses of treatment with Cobenfy for 5 weeks.…
Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil for improving whit…
This is a hybrid1, effectiveness-implementation study of yoga-based exercises (YE) as an adjunctive tool for rehabilitation among persons with Severe Mental Ill…
A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia
The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an i…
The primary purpose of this open-label phase 3 study is to evaluate the safety of HS-10380 on the incidence, severity, relationship to investigational product o…
This study aims to examine the effect of a schizophrenia scenario-based simulation on nursing students' knowledge, empathy, and caregiving competence. The study…